176 related articles for article (PubMed ID: 36740245)
1. Altering patterns of sensorimotor network in patients with different pathological diagnoses and glioma-related epilepsy under the latest glioma classification of the central nervous system.
Fang S; Li L; Weng S; Guo Y; Fan X; Jiang T; Wang Y
CNS Neurosci Ther; 2023 May; 29(5):1368-1378. PubMed ID: 36740245
[TBL] [Abstract][Full Text] [Related]
2. Decreasing Shortest Path Length of the Sensorimotor Network Induces Frontal Glioma-Related Epilepsy.
Fang S; Li L; Weng S; Guo Y; Zhang Z; Wang L; Fan X; Wang Y; Jiang T
Front Oncol; 2022; 12():840871. PubMed ID: 35252008
[TBL] [Abstract][Full Text] [Related]
3. Epilepsy enhance global efficiency of language networks in right temporal lobe gliomas.
Fang S; Wang Y; Jiang T
CNS Neurosci Ther; 2021 Mar; 27(3):363-371. PubMed ID: 33464718
[TBL] [Abstract][Full Text] [Related]
4. Epilepsy-Related Brain Network Alterations in Patients With Temporal Lobe Glioma in the Left Hemisphere.
Fang S; Zhou C; Fan X; Jiang T; Wang Y
Front Neurol; 2020; 11():684. PubMed ID: 32765403
[No Abstract] [Full Text] [Related]
5. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric mapping of white matter reorganizations in patients with frontal glioma-related epilepsy.
Zhang S; Zhao F; Yang X; Tan Q; Li S; Shao H; Su X; Gong Q; Yue Q
CNS Neurosci Ther; 2023 Aug; 29(8):2366-2376. PubMed ID: 37381706
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy alters brain networks in patients with insular glioma.
He Q; Yang Z; Xue B; Song X; Zhang C; Yin C; Li Z; Deng Z; Sun S; Qiao H; Xie J; Hou Z
CNS Neurosci Ther; 2024 Jun; 30(6):e14805. PubMed ID: 38887197
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
[TBL] [Abstract][Full Text] [Related]
9. Co-deletion of chromosome 1p/19q and IDH1/2 mutation in glioma subsets of brain tumors in Chinese patients.
Ren X; Cui X; Lin S; Wang J; Jiang Z; Sui D; Li J; Wang Z
PLoS One; 2012; 7(3):e32764. PubMed ID: 22427879
[TBL] [Abstract][Full Text] [Related]
10. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
[TBL] [Abstract][Full Text] [Related]
11. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
Chen SC; Lo CM; Wang SH; Su EC
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results.
Ballester LY; Huse JT; Tang G; Fuller GN
Hum Pathol; 2017 Nov; 69():15-22. PubMed ID: 28549927
[TBL] [Abstract][Full Text] [Related]
13. Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.
Branzoli F; Pontoizeau C; Tchara L; Di Stefano AL; Kamoun A; Deelchand DK; Valabrègue R; Lehéricy S; Sanson M; Ottolenghi C; Marjańska M
Neuro Oncol; 2019 Jun; 21(6):765-774. PubMed ID: 30726924
[TBL] [Abstract][Full Text] [Related]
14. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
[TBL] [Abstract][Full Text] [Related]
15. The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.
Zhao K; Sun G; Wang Q; Xue Z; Liu G; Xia Y; Yao A; Zhao Y; You N; Yang C; Xu B
Acad Radiol; 2021 Jul; 28(7):e189-e198. PubMed ID: 32359929
[TBL] [Abstract][Full Text] [Related]
16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
17. Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
Hu X; Martinez-Ledesma E; Zheng S; Kim H; Barthel F; Jiang T; Hess KR; Verhaak RGW
Neuro Oncol; 2017 Jun; 19(6):786-795. PubMed ID: 28340142
[TBL] [Abstract][Full Text] [Related]
18.
Cicone F; Carideo L; Scaringi C; Arcella A; Giangaspero F; Scopinaro F; Minniti G
Ann Nucl Med; 2019 Apr; 33(4):295-302. PubMed ID: 30607877
[TBL] [Abstract][Full Text] [Related]
19. Determining chromosomal arms 1p/19q co-deletion status in low graded glioma by cross correlation-periodogram pattern analysis.
Bhattacharya D; Sinha N; Saini J
Sci Rep; 2021 Dec; 11(1):23866. PubMed ID: 34903768
[TBL] [Abstract][Full Text] [Related]
20. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
